EquityZen Growth Technology Fund LLC - Series 1137
Raised
$282K
Investors
17
Min Invest
$10,001
AltStreet Analysis
·Generated from EDGAR primary sources
EquityZen Growth Technology Fund LLC - Series 1137 is a Delaware-domiciled pooled investment vehicle filed by EquityZen Advisors that raised $282K from 17 investors with a $10K minimum investment under Rule 506(b) and 3(c)(1) exemptions. This series is part of the EquityZen platform, which operates 1889+ related pre-IPO secondary market vehicles.
This pre-IPO fund uses the standard 506(b)/3(c)(1) exemption structure common to private secondary market vehicles, with a $10K minimum investment threshold accessible to accredited investors. The offering size and investor count are consistent with typical EquityZen series vehicles targeting concentrated exposure to individual late-stage private companies.
Data Flags
EDGAR Filing Data
Form D — Primary Source
View on SEC.govRelated Persons (Form D)
Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.
EquityZen Advisors LLC
Executive Officer, Director · New York, NY
Richard Thoms
Executive Officer · Salt Lake City, UT
Assure Fund Management II LLC
Director · Salt Lake City, UT
Philip Haslett
Executive Officer, Director · New York, NY
Is this your offering?
Claim this profile to add contact information, team members, LinkedIn profiles, fund history, and additional financial data. EDGAR-sourced data and AltStreet analysis cannot be edited, but corrections can be requested for verifiable inaccuracies.
Data Methodology
Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. EDGAR entity profiles and deal-level data are reviewed by AltStreet analysts with backgrounds in corporate finance and securities law — cross-referenced against offering circulars, audited financial statements, and primary regulatory filings before publication. Platform-provided information, where present, is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. Platforms may request factual corrections for demonstrable inaccuracies by contacting [email protected]. This page does not constitute investment advice.